维普中文期刊产品整合服务
50篇 您的检索式:作者名="SOGAARD B"
    题名 作者 年代 出处 被引量
1Pharmacokineties and pharmacady nam2 ics of a p remixed formulation of soluble and p rotamine-re tarded insulin aspart显示文摘 Sogaard B RiisA 2000Eur J Clin Pharmacol2000,56,5:1
2Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart显示文摘Jacobsen LV Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,:1
3The effect of cimetidine or ome- prazole on the pharmacokinetics of escitalopram显示文摘Mailing D Poulsen M Sogaard B 2005Br J Clin Pharma- col2005,60,3:1
4Long-term exercise of young and adult female rats:effect on femoral neck biomechanical competence and bone structure显示文摘Sogaard C H Danielsen C C Thorling E B 1994J Bone Miner Res1994,9,3:1
5pharmacokineticas and pharmacodvaics of a premixed formulation of soluble and protamine-retarded insulin aspart显示文摘Jacobsen LV Sogaard B Riis A 2000Eur J CIin Pharmacol2000,56,5:1
6Pharmacokineticas and pharmacodynamics of a premixed formulation of solule and protamine-retarded insulin aspart显示文摘Jacobsen LV Sogaard B Riis A 2000Eur J Clin Pharmaeol2000,56,:1
7Pharmacokinetics and phar-macodynamics of a premixed formulation of soluble and prota-mine-retarded insulin aspart显示文摘Jacobsen LV Sogaard B Riis A 0,,05:1
8A positive allelopathic effect of corn cockle, Agrostemma githago , on wheat, Triticum aestivum 显示文摘Sogaard B Doll H 1992Ca- nadian Journal of Botany-revue Canadienne de Botanique1992,70,:1
9Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded inantin aspart显示文摘Jacobsen L Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,5:1
10Pharmaeokinetics and pharmacodymics of a premixed formulation of soluble and protamine-retarded insulin aspart显示文摘Jacobsen L Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,5:1
11Speckle-tracking echocardiography for predicting outcome in chronic aortic regurgitation during conservative management and after surgery显示文摘Olsen N T Sogaard P Larsson H B 2011JACC Cardiovasc Imaging2011,4,3:1
12Phalmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine retarded insulin aspart显示文摘Jacobsen L Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,5:1
13The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects 显示文摘Sogaard B Mengel H Rao N 2005J Clin Pharmacol2005,45,12:1
14The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects显示文摘SOGAARD B MENGEL H RAO N 2005J Clin Pharmacol2005,45,12:1
15Phannacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart显示文摘Jacobsen L Sogaard B Riis A 2000Eur J Clio Pharmacol2000,56,5:1
16The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects显示文摘Sogaard B Mengel H Rao N 2005J Clin Pharmacol2005,45,12:1
17The phannacokineties of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects 显示文摘Sogaard B Mengel H Rao N 2005J Clin Pharmacol2005,45,:1
18An Econometric Analysis of Health Care Expenditure : A Cross-Section Study of the OECD Countries 显示文摘Gerdtham UG Sogaard J Andersson F Jonsson B 1992Journal of Health Economics1992,,11:1
19Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine - retarded insulin aspart 显示文摘Jacobsen L Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,39:1
20Pharmacokineticas and pharmacodynamics of a premixed formulation of soluble and protamineretarded insulin aspart显示文摘Jacobsen LV Sogaard B Riis A 2000Eur J Clin Pharmacol2000,56,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费